DOCSLIB.ORG

Cervical Changes

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Cervical Changes UNDERSTANDING CERVICAL CHANGES A HEALTH GUIDE FOR WOMEN PATIENT U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES &family National Institutes of Health EDUCATION National Cancer Institute A Pap Test Showed Cell Changes in Your Cervix You’re probably reading this booklet because your health care provider told you that your recent Pap test (sometimes called a Pap smear) showed cell changes in your cervix. Although it is quite common to feel uneasy about your Pap test results, it may comfort you to know that each year more than 3 million women receive similar results. Not All Cell Changes Are Cancer The good news is that almost always, women with cell changes do not have cancer of the cervix (also called cervical cancer). But it is important that you protect your health by getting the follow-up tests and care that your health care provider suggests. Cell changes do not mean that you will get cancer of the cervix. And because your cell changes were found, simple tests or treatments can help you. When cell changes are found and treated early, almost all women can avoid getting cervical cancer. Getting Your Questions Answered So what is the next step? What do your results mean? Does this mean you need treatment and, if so, what kind? This booklet helps answer these questions and discusses: “I didn’t understand my results at first— I Types of changes in your cervix and a part of me didn’t want to I Common tests and treatments understand. But I knew this was I How to find the support and resources you need important . and in the end, You will probably have other questions, or you might be everything turned out fine.” concerned about the choices you may need to make. These —MARLENE, AGE 45 reactions are normal. But understanding your Pap test results—and what to expect when the results are not normal—can help you make informed decisions and plan your next steps. A dictionary, beginning on page 31, explains terms that may be new to you. These terms will appear in bold. Understanding Cervical Changes What Is the Cervix?................................................................1 Finding the Support You Need.............................................13 Common Changes in Cervical Cells ........................................2 Table 1: What Your Pap Test/HPV Test Results Cell Changes Caused by HPV Are a Special Concern ..............3 Mean and Follow-Up .............................................14 Other Risk Factors for Cervical Cancer.....................................3 Table 2: Tests or Follow-Up Treatments That Health Care Providers Use for Abnormal What Should I Know About HPV Infection?..........................4 Pap Tests ...............................................................18 How Women Get HPV ..............................................................4 Table 3: What Does It Mean: Results From How Can I Tell if I Have HPV? And What Can Your Biopsy or Endocervical Curettage ................22 Happen to Me if I Have It?.................................................4 How Is an HPV Infection Treated? ...........................................5 Table 4: Treatments for Major Cell Changes......................24 If I Have HPV and It Goes Away, Can I Get It Again? .............5 Resources..............................................................................28 Finding Abnormal Cells..........................................................6 Dictionary.............................................................................31 The Pap Test ..............................................................................6 The HPV Test.............................................................................7 How Is the HPV Test Done?......................................................7 When Is an HPV Test Useful? ...................................................7 What Do My Pap Test Results Mean? ....................................8 Why Did I Get an Unclear Result? ...........................................9 Is It All Right if I Don’t Get Tested Again Right Away? .........10 Questions To Ask Your Health Care Provider.......................11 Getting a Second Opinion....................................................12 1 What Is the Cervix? The cervix is the narrow, lower part of the uterus (where the baby grows when a woman is pregnant). During a pelvic exam, the doctor or nurse practitioner can see the cervix at the upper end of the vagina. The cervix has an opening to the endocervical canal. This opening lets blood flow from the uterus into the vagina during a woman’s menstrual period. During childbirth, the cervix opens much wider to let the baby pass through. The surface lining of the cervix is made up of two different types of cells: I Tall cells, called glandular cells (or columnar cells) toward the top of the endocervical canal (above the cervix). They make mucus, which helps guard the entrance to the uterus. I Thin, flat cells, called squamous epithelial cells (or squamous cells). Arranged in layers, they protect the tissues underneath them. Pap tests can help health care providers find changes in these cells. 2 3 Cell Changes Caused by HPV Are a Special Concern Some cell changes are a sign of a certain viral infection called HPV (human papillomavirus). In most women, HPV infections go away on their own. Sometimes, the cells infected with HPV will become precancerous. These precancerous cells can become normal normal and precancerous cervical cancer (called invasive cancer of the cervix). They can cervical cells precancerous mix cervical cells grow and spread, invading nearby tissues and possibly spreading throughout the body. An HPV test, which is done much like a Common Changes in Cervical Cells Pap test, can detect the virus in cervical cells. Cervical cells can go through many types of changes that are not cancer. Many times these changes will go away on their own. What is HPV? These changes can be caused by: I It is a very common virus. I Inflammation (redness and swelling) I There are more than 100 types. I An infection (bacterial, viral, or yeast) I About 15 types can cause cervical cancer. I Growths such as benign polyps or cysts I Some types cause warts on the fingers or feet but do not cause I Changes in hormones from pregnancy or menopause cancer. These cell changes are very common and are not related to cancer. I Other types cause warts in the genital area that are not cancerous. But they sometimes make these cells look like abnormal cells. So your health care provider may suggest that you repeat your Pap test or have other follow-up tests to be certain you don’t Other Risk Factors for Cervical Cancer have any cell changes. (See the tables beginning on page 16 for HPV is the most important cause of and risk factor for cervical more information.) cancer. But studies have shown that other factors may act together with HPV to increase your risk of developing cervical cancer. These factors include cigarette smoking and having given birth to many Although most cell changes in the cervix are not cancer, children. Also, if you have a weak immune system, you may be at it is still important to get a Pap test at least once every higher risk because your body may not be able to clear up HPV on 3 years to be sure. its own. For example, if you take medicine to block your body’s immune response or if you have HIV, you may be at higher risk. 4 5 What Should I Know About HPV Infection? “I was really afraid when I found out How Women Get HPV I have HPV, but Almost all HPV that affects the cervix is spread by sex talking to the nurse (through intimate genital to genital contact including vaginal or really helped me anal intercourse, finger to genital contact, and finger to anal understand what it contact). It is rarely spread through oral sex. You are at higher risk is and what we can of getting HPV if: do about it…” I You have had more than one sex partner, or —JESSICA, AGE 28 I Your sex partner(s) has had other partners. If your health care provider finds you have HPV, your sex partner(s) should also get checked. They usually will have no symptoms. For more information about HPV and how to protect yourself, see the Resources section (pages 28–30). How Is an HPV Infection Treated? Although HPV itself cannot be treated, the cell changes that it How Can I Tell if I Have HPV? causes can be treated. Simple treatments that remove or destroy And What Can Happen to Me if I Have It? the cells may prevent cancer. This is why regular pelvic exams and Pap tests are important, along with care for cell changes. Most women with HPV of the cervix do not know they have it. Most of the time, it does not cause any symptoms. Certain types of HPV can cause warts on the outside of the genitals, but the only If I Have HPV and It Goes Away, way to know for sure whether you have HPV is by seeing your Can I Get It Again? health care provider. If you or your partner has HPV, you will share it until your bodies’ Almost all HPV infections clear up on their own. Many women immune systems get rid of the infection. If you have sex only with with HPV will have cell changes at least briefly within a few each other, you will not pass the HPV virus back and forth. This is months to a year after getting the virus. Most types of HPV do not because when the HPV goes away, the immune system will lead to cancer. But if HPV does not go away, you are more at risk remember that HPV type and keep you from getting it again. Even of developing a precancerous change that needs to be treated. It is though you are protected from one type of HPV, you are not best to see your health care provider on a regular basis. protected from getting the many other types of HPV. 6 7 Finding Abnormal Cells The HPV Test Almost all cervical cancer begins as an infection with the virus called HPV. An HPV test, which is done much like a Pap test, can The Pap Test detect the virus in cervical cells.
Load more

Recommended publications
  • Chapter 28 *Lecture Powepoint
    Chapter 28 *Lecture PowePoint The Female Reproductive System *See separate FlexArt PowerPoint slides for all figures and tables preinserted into PowerPoint without notes. Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display. Introduction • The female reproductive system is more complex than the male system because it serves more purposes – Produces and delivers gametes – Provides nutrition and safe harbor for fetal development – Gives birth – Nourishes infant • Female system is more cyclic, and the hormones are secreted in a more complex sequence than the relatively steady secretion in the male 28-2 Sexual Differentiation • The two sexes indistinguishable for first 8 to 10 weeks of development • Female reproductive tract develops from the paramesonephric ducts – Not because of the positive action of any hormone – Because of the absence of testosterone and müllerian-inhibiting factor (MIF) 28-3 Reproductive Anatomy • Expected Learning Outcomes – Describe the structure of the ovary – Trace the female reproductive tract and describe the gross anatomy and histology of each organ – Identify the ligaments that support the female reproductive organs – Describe the blood supply to the female reproductive tract – Identify the external genitalia of the female – Describe the structure of the nonlactating breast 28-4 Sexual Differentiation • Without testosterone: – Causes mesonephric ducts to degenerate – Genital tubercle becomes the glans clitoris – Urogenital folds become the labia minora – Labioscrotal folds
    [Show full text]
  • Chapter 24 Primary Sex Organs = Gonads Produce Gametes Secrete Hormones That Control Reproduction Secondary Sex Organs = Accessory Structures
    Anatomy Lecture Notes Chapter 24 primary sex organs = gonads produce gametes secrete hormones that control reproduction secondary sex organs = accessory structures Development and Differentiation A. gonads develop from mesoderm starting at week 5 gonadal ridges medial to kidneys germ cells migrate to gonadal ridges from yolk sac at week 7, if an XY embryo secretes SRY protein, the gonadal ridges begin developing into testes with seminiferous tubules the testes secrete androgens, which cause the mesonephric ducts to develop the testes secrete a hormone that causes the paramesonephric ducts to regress by week 8, in any fetus (XX or XY), if SRY protein has not been produced, the gondal ridges begin to develop into ovaries with ovarian follicles the lack of androgens causes the paramesonephric ducts to develop and the mesonephric ducts to regress B. accessory organs develop from embryonic duct systems mesonephric ducts / Wolffian ducts eventually become male accessory organs: epididymis, ductus deferens, ejaculatory duct paramesonephric ducts / Mullerian ducts eventually become female accessory organs: oviducts, uterus, superior vagina C. external genitalia are indeterminate until week 8 male female genital tubercle penis (glans, corpora cavernosa, clitoris (glans, corpora corpus spongiosum) cavernosa), vestibular bulb) urethral folds fuse to form penile urethra labia minora labioscrotal swellings fuse to form scrotum labia majora urogenital sinus urinary bladder, urethra, prostate, urinary bladder, urethra, seminal vesicles, bulbourethral inferior vagina, vestibular glands glands Strong/Fall 2008 Anatomy Lecture Notes Chapter 24 Male A. gonads = testes (singular = testis) located in scrotum 1. outer coverings a. tunica vaginalis =double layer of serous membrane that partially surrounds each testis; (figure 24.29) b.
    [Show full text]
  • Developmental Abnormalities Easy to Misdiagnose
    8 Gynecology O B .GYN. NEWS • March 15, 2005 Developmental Abnormalities Easy to Misdiagnose BY JANE SALODOF MACNEIL inappropriate surgery, according to Dr. even an entity called obstructed hemi- Abnormalities of the vulva include con- Contributing Writer Zurawin, chief of the section of pediatric vagina.” genital labial fusion, which he said could and adolescent gynecology at Baylor and Clitoral hypertrophy is the only devel- be corrected with a simple flap proce- H OUSTON — Developmental abnor- of the gynecology service at Texas Chil- opmental abnormality of the clitoris, ac- dure. Surgery is rarely used, however, for malities of the vulva and vagina are often dren’s Hospital in Houston. cording to Dr. Zurawin. It used to be acquired labial agglutination. “This is one easy to correct, but also easy to misdiag- “You need to be familiar with the syn- treated by clitoridectomy with “very un- of most common referrals from pediatri- nose, Robert K. Zurawin, M.D., warned at dromes before you treat. Many people satisfactory results,” he said, describing cians, because they don’t know what to do a conference on vulvovaginal diseases are confronted with these conditions, and more conservative procedures in use to- with it and they are afraid,” Dr. Zurawin sponsored by Baylor College of Medicine. they don’t know what they really are,” he day. “This is mainly a cosmetic problem said. Many physicians have not been trained said. “With the obstructions, for example, for patients, and the surgical management He attributed most cases to diaper rash, to recognize these rare disorders and, as a they may just think it is an imperforate hy- is resection of the enlarged clitoris,” he bubble baths, and detergents that can in- result, run the risk of doing excessive or men and are not even aware that there is said.
    [Show full text]
  • 2021 – the Following CPT Codes Are Approved for Billing Through Women’S Way
    WHAT’S COVERED – 2021 Women’s Way CPT Code Medicare Part B Rate List Effective January 1, 2021 For questions, call the Women’s Way State Office 800-280-5512 or 701-328-2389 • CPT codes that are specifically not covered are 77061, 77062 and 87623 • Reimbursement for treatment services is not allowed. (See note on page 8). • CPT code 99201 has been removed from What’s Covered List • New CPT codes are in bold font. 2021 – The following CPT codes are approved for billing through Women’s Way. Description of Services CPT $ Rate Office Visits New patient; medically appropriate history/exam; straightforward decision making; 15-29 minutes 99202 72.19 New patient; medically appropriate history/exam; low level decision making; 30-44 minutes 99203 110.77 New patient; medically appropriate history/exam; moderate level decision making; 45-59 minutes 99204 165.36 New patient; medically appropriate history/exam; high level decision making; 60-74 minutes. 99205 218.21 Established patient; evaluation and management, may not require presence of physician; 99211 22.83 presenting problems are minimal Established patient; medically appropriate history/exam, straightforward decision making; 10-19 99212 55.88 minutes Established patient; medically appropriate history/exam, low level decision making; 20-29 minutes 99213 90.48 Established patient; medically appropriate history/exam, moderate level decision making; 30-39 99214 128.42 minutes Established patient; comprehensive history exam, high complex decision making; 40-54 minutes 99215 128.42 Initial comprehensive
    [Show full text]
  • Agreement Between Endocervical Brush and Endocervical Curettage in Patients Undergoing Repeat Endocervical Sampling
    Agreement Between Endocervical Brush and Endocervical Curettage in Patients Undergoing Repeat Endocervical Sampling Meredith J. Alston MD David W. Doo MD Sara E. Mazzoni MD MPH Elaine H. Stickrath MD Denver Health Medical Center University of Colorado Department of Obstetrics and Gynecology Background • Women with abnormal Pap tests referred for colposcopy frequently require sampling of the endocervix • ASCCP deems both the endocervical brush (ECB) and the endocervical currette (ECC) appropriate means of collecting endocervical samples (1) • Both have advantages and disadvantages, and it is unclear if one modality is superior Background • ECB has good sensitivity for endocervical lesions, it has poor specificity, ranging from 26- 38%2,3 • ECC has an excellent negative predictive value of 99.4% in women who had a satisfactory colposcopy • ECB is better tolerated by the patient, but runs the risk of contamination from the ectocervix • ECC is less likely to obtain an adequate sample Background • The results from the endocervical sample may influence clinical management after colposcopy. • Certain treatment options for high grade squamous intraepithelial neoplasia are available only to women with negative endocervical sampling. ▫ Ablative techniques ▫ Expectant management Background • Over concerns related to potential complications of excisional treatments, as well as over- treatment, there has been a push to re-introduce ablative techniques and, in appropriate clinical circumstances, expectant management, into the routine treatment of patients with cervical cancer precursors (12). Background • At our institution, it is our concern that due to the possibility of contamination from the ectocervix, a positive ECB may not represent a true positive endocervical sample. • We do not use a sleeve • Positive ECBs return for ECC if otherwise a candidate for ablative therapy or expectant management Objective • To describe the agreement between these two modalities of endocervical sampling.
    [Show full text]
  • The Reproductive System
    27 The Reproductive System PowerPoint® Lecture Presentations prepared by Steven Bassett Southeast Community College Lincoln, Nebraska © 2012 Pearson Education, Inc. Introduction • The reproductive system is designed to perpetuate the species • The male produces gametes called sperm cells • The female produces gametes called ova • The joining of a sperm cell and an ovum is fertilization • Fertilization results in the formation of a zygote © 2012 Pearson Education, Inc. Anatomy of the Male Reproductive System • Overview of the Male Reproductive System • Testis • Epididymis • Ductus deferens • Ejaculatory duct • Spongy urethra (penile urethra) • Seminal gland • Prostate gland • Bulbo-urethral gland © 2012 Pearson Education, Inc. Figure 27.1 The Male Reproductive System, Part I Pubic symphysis Ureter Urinary bladder Prostatic urethra Seminal gland Membranous urethra Rectum Corpus cavernosum Prostate gland Corpus spongiosum Spongy urethra Ejaculatory duct Ductus deferens Penis Bulbo-urethral gland Epididymis Anus Testis External urethral orifice Scrotum Sigmoid colon (cut) Rectum Internal urethral orifice Rectus abdominis Prostatic urethra Urinary bladder Prostate gland Pubic symphysis Bristle within ejaculatory duct Membranous urethra Penis Spongy urethra Spongy urethra within corpus spongiosum Bulbospongiosus muscle Corpus cavernosum Ductus deferens Epididymis Scrotum Testis © 2012 Pearson Education, Inc. Anatomy of the Male Reproductive System • The Testes • Testes hang inside a pouch called the scrotum, which is on the outside of the body
    [Show full text]
  • Colposcopy.Pdf
    CCololppooscoscoppyy ► Chris DeSimone, M.D. ► Gynecologic Oncology ► Images from Colposcopy Cervical Pathology, 3rd Ed., 1998 HistoHistorryy ► ColColpposcopyoscopy wwasas ppiioneeredoneered inin GGeermrmaanyny bbyy DrDr.. HinselmannHinselmann dduriurinngg tthhee 19201920’s’s ► HeHe sousougghtht ttoo prprooveve ththaatt micmicrroscopicoscopic eexaminxaminaationtion ofof thethe cervixcervix wouwoulldd detectdetect cervicalcervical ccancanceerr eeararlliierer tthhaann 44 ccmm ► HisHis workwork identidentiifiefiedd severalseveral atatyypicalpical appeappeararanancceses whwhicichh araree stistillll usedused ttooddaay:y: . Luekoplakia . Punctation . Felderung (mosaicism) Colposcopy Cervical Pathology 3rd Ed. 1998 HistoHistorryy ► ThrThrooughugh thethe 3030’s’s aanndd 4040’s’s brbreaeaktkthrhrouougghshs wwereere mamaddee regregaarrddinging whwhicichh aapppepeararancanceess wweerere moremore liklikelelyy toto prprogogressress toto invinvaasivesive ccaarcinomrcinomaa;; HHOOWEWEVVERER,, ► TheThessee ffiinndingsdings wweerere didifffficiculultt toto inteinterrpretpret sincesince theythey werweree notnot corcorrrelatedelated wwithith histologhistologyy ► OneOne resreseaearcrchherer wwouldould claclaiimm hhiiss ppatatientsients wwithith XX ffindindiingsngs nevernever hahadd ccaarcinomarcinoma whwhililee aannothotheerr emphemphaatiticcallyally belibelieevedved itit diddid ► WorldWorld wiwidede colposcopycolposcopy waswas uunnderderuutitillizizeedd asas aa diadiaggnosticnostic tooltool sseeconcondadaryry ttoo tthheseese discrepadiscrepannciescies HistoHistorryy
    [Show full text]
  • RELATIVE VALUE UNITS (RVUS) and RELATED INFORMATION—Continued
    Federal Register / Vol. 68, No. 158 / Friday, August 15, 2003 / Proposed Rules 49129 ADDENDUM B.—RELATIVE VALUE UNITS (RVUS) AND RELATED INFORMATION—Continued Physician Non- Mal- Non- 1 CPT/ Facility Facility 2 MOD Status Description work facility PE practice acility Global HCPCS RVUs RVUs PE RVUs RVUs total total 42720 ....... ........... A Drainage of throat ab- 5.42 5.24 3.93 0.39 11.05 9.74 010 scess. 42725 ....... ........... A Drainage of throat ab- 10.72 N/A 8.26 0.80 N/A 19.78 090 scess. 42800 ....... ........... A Biopsy of throat ................ 1.39 2.35 1.45 0.10 3.84 2.94 010 42802 ....... ........... A Biopsy of throat ................ 1.54 3.17 1.62 0.11 4.82 3.27 010 42804 ....... ........... A Biopsy of upper nose/ 1.24 3.16 1.54 0.09 4.49 2.87 010 throat. 42806 ....... ........... A Biopsy of upper nose/ 1.58 3.17 1.66 0.12 4.87 3.36 010 throat. 42808 ....... ........... A Excise pharynx lesion ...... 2.30 3.31 1.99 0.17 5.78 4.46 010 42809 ....... ........... A Remove pharynx foreign 1.81 2.46 1.40 0.13 4.40 3.34 010 body. 42810 ....... ........... A Excision of neck cyst ........ 3.25 5.05 3.53 0.25 8.55 7.03 090 42815 ....... ........... A Excision of neck cyst ........ 7.07 N/A 5.63 0.53 N/A 13.23 090 42820 ....... ........... A Remove tonsils and ade- 3.91 N/A 3.63 0.28 N/A 7.82 090 noids.
    [Show full text]
  • New Insights Into Human Female Reproductive Tract Development
    UCSF UC San Francisco Previously Published Works Title New insights into human female reproductive tract development. Permalink https://escholarship.org/uc/item/7pm5800b Journal Differentiation; research in biological diversity, 97 ISSN 0301-4681 Authors Robboy, Stanley J Kurita, Takeshi Baskin, Laurence et al. Publication Date 2017-09-01 DOI 10.1016/j.diff.2017.08.002 Peer reviewed eScholarship.org Powered by the California Digital Library University of California Differentiation 97 (2017) xxx–xxx Contents lists available at ScienceDirect Differentiation journal homepage: www.elsevier.com/locate/diff New insights into human female reproductive tract development MARK ⁎ Stanley J. Robboya, , Takeshi Kuritab, Laurence Baskinc, Gerald R. Cunhac a Department of Pathology, Duke University, Davison Building, Box 3712, Durham, NC 27710, United States b Department of Cancer Biology and Genetics, The Comprehensive Cancer Center, Ohio State University, 460 W. 12th Avenue, 812 Biomedical Research Tower, Columbus, OH 43210, United States c Department of Urology, University of California, 400 Parnassus Avenue, San Francisco, CA 94143, United States ARTICLE INFO ABSTRACT Keywords: We present a detailed review of the embryonic and fetal development of the human female reproductive tract Human Müllerian duct utilizing specimens from the 5th through the 22nd gestational week. Hematoxylin and eosin (H & E) as well as Urogenital sinus immunohistochemical stains were used to study the development of the human uterine tube, endometrium, Uterovaginal canal myometrium, uterine cervix and vagina. Our study revisits and updates the classical reports of Koff (1933) and Uterus Bulmer (1957) and presents new data on development of human vaginal epithelium. Koff proposed that the Cervix upper 4/5ths of the vagina is derived from Müllerian epithelium and the lower 1/5th derived from urogenital Vagina sinus epithelium, while Bulmer proposed that vaginal epithelium derives solely from urogenital sinus epithelium.
    [Show full text]
  • Diagnostic Tests for Vaginosis/Vaginitis
    Alberta Heritage Foundation for Medical Research Diagnostic tests for vaginosis/vaginitis Christa Harstall and Paula Corabian October 1998 HTA12 Diagnostic tests for vaginosis/vaginitis Christa Harstall and Paula Corabian October 1998 © Copyight Alberta Heritage Foundation for Medical Research, 1998 This Health Technology Assessment Report has been prepared on the basis of available information of which the Foundation is aware from public literature and expert opinion, and attempts to be current to the date of publication. The report has been externally reviewed. Additional information and comments relative to the Report are welcome, and should be sent to: Director, Health Technology Assessment Alberta Heritage Foundation for Medical Research 3125 Manulife Place, 10180 - 101 Street Edmonton Alberta T5J 3S4 CANADA Tel: 403-423-5727, Fax: 403-429-3509 This study is based, in part, on data provided by Alberta Health. The interpretation of the data in the report is that of the authors and does not necessarily represent the views of the Government of Alberta. ISBN 1-896956-15-7 Alberta's health technology assessment program has been established under the Health Research Collaboration Agreement between the Alberta Heritage Foundation for Medical Research and the Alberta Health Ministry. Acknowledgements The Alberta Heritage Foundation for Medical Research is most grateful to the following persons for their comments on the draft report and for provision of information. The views expressed in the final report are those of the Foundation. Dr. Jane Ballantine, Section of General Practice, Calgary Dr. Deirdre L. Church, Microbiology, Calgary Laboratory Services, Calgary Dr. Nestor N. Demianczuk, Royal Alexandra Hospital, Edmonton Dr.
    [Show full text]
  • Key Points: • a Pap Test and Pelvic Exam Are Important Parts of A
    Key Points: • A Pap test and pelvic exam are important parts of a woman’s routine health care because they can detect cancer or abnormalities that may lead to cancer of the cervix (see Question 3). • Women should have a Pap test at least once every three years, beginning about three years after they begin to have sexual intercourse, but no later than age 21 (see Question 6). • If the Pap test shows abnormalities, further tests an/or treatment may be necessary (see Question 11). • Human papillomavirus (HPV) infection is the primary risk factor for cervical cancer (see Question 13). 1. What is a Pap test? The Pap test (sometimes called a Pap smear) is a way to examine cells collected from the cervix (the lower, narrow end of the uterus). The main purpose of the Pap test is to find abnormal cell changes that may arise from cervical cancer or before cancer develops. 2. What is a pelvic exam? In a pelvic exam, the uterus, vagina, ovaries, fallopian tubes, bladder, and rectum are felt to find any abnormality in their shape or size. During a pelvic exam, an instrument called a speculum is used to widen the vagina so that the upper portion of the vagina and the cervix can be seen. 3. Why are a Pap test and pelvic exam important? A Pap test and pelvic exam are important parts of a woman’s routine health care because they can detect abnormalities that may lead to invasive cancer of the cervix. These abnormalities can be treated before cancer develops.
    [Show full text]
  • Obstetrics and Gyneclogy
    3/28/2016 Obstetrics and Gynecology Presented by: Peggy Stilley, CPC, CPC-I, CPMA, CPB, COBGC Objectives • Procedures • Pregnancy • Payments • Patient Relationships 1 3/28/2016 Female Genital Anatomy Terminology and Abbreviations • Endometriosis • Neoplasm • BUS • TAH/BSO • G3P2 2 3/28/2016 Procedures • Hysterectomy • Prolapse repairs • IUDs • Colposcopy Hysterectomy • Approach • Open • Vaginal • Total Laparoscopic • Laparoscopic assisted • Extent • Total • Subtotal • Supracervical • Diagnosis 3 3/28/2016 CPT Codes • Abdominal 58150 – • With or without removal tubes/ovaries 58240 • Some additional services • Vaginal 58260-58270 • Size of uterus < 250 grams, > 250 grams 58275-58294 • Additional services CPT Codes • LAVH 58541-58544 • Detach uterus , cervix, and structures through the scope 58548-58554 • Uterus removed thru the vagina • TLH • Detach structures laparoscopically entire 58570- 58573 uterus, cervix, bodies • Removed thru the vagina or abdomen • LSH • Detaching structures through the scope, 58541 – 58544 leaving the cervix • Morcellating – removing abdominally 4 3/28/2016 Hysterectomy Additional procedures performed • Tubes & Ovaries removed • Enterocele repair • Repairs for incontinence • Marshall-Marchetti-Krantz • Colporrhaphy • Colpo-urethropexy • Urethral Sling • TVT, TOT 5 3/28/2016 Procedures • 57288 Sling • 57240 Anterior Repair • 57250 Posterior Repair • +57267 Add on code for mesh/graft • 57260 Combo of A&P • 57425 Laparoscopic Colpopexy • 57280 Colpopexy, Abdominal approach • 57282 Colpopexy, vaginal approach Example 1 PREOPERATIVE DIAGNOSES: 1. Menorrhagia unresponsive to medical treatment with resulting chronic blood loss anemia POSTOPERATIVE DIAGNOSES: 1. Menorrhagia 2. Blood loss anemia TITLE OF SURGERY: Total abdominal hysterectomy ANESTHESIA: GENERAL ENDOTRACHEAL ANESTHESIA. INDICATIONS: The patient is a lovely 52-year-old female who presented with menorrhagia that is non- responsive to medical treatment.
    [Show full text]